EFMC
VRTX icon

Empire Financial Management Company’s Vertex Pharmaceuticals VRTX Stock Holding History

Empire Financial Management Company’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-1,000
Closed -$315K – 200
2023
Q1 		$315K Buy
+1,000
New +$300K 0.13% 157

Other funds holding VRTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Empire Financial Management Company's VRTX Position: Q2 2023 in Review

Empire Financial Management Company sold out of Vertex Pharmaceuticals (VRTX) in Q2 2023, closing a stake of 1,000 shares — an estimated $315K sold.

Empire Financial Management Company first reported a position in VRTX in Q1 2023 and held it in 1 quarter. The position peaked at $315K in Q1 2023. 1,286 funds tracked by Wall St. Rank hold VRTX as of Q2 2023.

  • Empire Financial Management Company reported no remaining Vertex Pharmaceuticals position as of Q2 2023 after selling out during the quarter.
  • Empire Financial Management Company sold 1,000 Vertex Pharmaceuticals shares in Q2 2023, an estimated $315K.
  • Empire Financial Management Company first reported a position in Vertex Pharmaceuticals in Q1 2023 and held it in 1 quarter.
  • Empire Financial Management Company's Vertex Pharmaceuticals position peaked at $315K in Q1 2023.
  • 1,286 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2023.

Based on Empire Financial Management Company's 13F filing for Q2 2023, filed 27 Jul 2023.